TNF and juvenile idiopathic arthritis: JIA’s economic impact was investigated in seven of the studies [2, 13, 14, 31–34], one study looked into etanercept’s (TNF-alpha inhibitor) impact on overall costs [35], and another investigated JIA hydrotherapy’s cost-effectiveness [36].